• Users Online: 20031
  • Home
  • Print this page
  • Email this page

    Article Cited by others

BRIEF COMMUNICATION

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia

Rishi Pukhraj, Rishi Ekta, Venkataraman Anusha, Gopal Lingam, Sharma Tarun, Bhende Muna, Ratra Dhanashree, Sen Pratik Ranjan, Sen Parveen

Year : 2011| Volume: 59| Issue : 3 | Page no: 242-246

   This article has been cited by
 
1 Treatment of myopic choroidal neovascularization: a network meta-analysis and review
Laura Glachs, Stefan Embacher, Andrea Berghold, Brigitte Wildner, Monja Michelitsch, Anna Tscherne, Andreas Wedrich, Laura Posch-Pertl
Graefe's Archive for Clinical and Experimental Ophthalmology. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA
Erqian Wang,Youxin Chen
Retina. 2013; 33(7): 1375
[Pubmed]  [Google Scholar] [DOI]
3 Predictive Factors for Visual Outcome after Treatment for Myopic Choroidal Neovascularization
Ha Na Oh,Joo Eun Lee,Hyun Woong Kim,Il Han Yun
Journal of the Korean Ophthalmological Society. 2013; 54(4): 610
[Pubmed]  [Google Scholar] [DOI]
4 Low-fluence photodynamic therapy for early onset choroidal neovascular membrane following laser in situ keratomileusis
GeorgeJ Manayath, Venkatapathy Narendran, Anuradha Ganesh, Saurabh Arora
Indian Journal of Ophthalmology. 2012; 60(6): 584
[Pubmed]  [Google Scholar] [DOI]
5 Myopic CNV | [Myope CNV]
Voykov, B., Ziemssen, F.
Klinische Monatsblatter fur Augenheilkunde. 2011; 228(9): 762-770
[Pubmed]  [Google Scholar]

 

Read this article